---
title: Long-term Outcome After Helical Tomotherapy Following Breast Conserving Surgery
  for Ductal Carcinoma In Situ
date: '2024-07-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39043035/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240724183054&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Background: This retrospective study aimed to investigate the outcomes
  and adverse events (AEs) associated with adjuvant radiotherapy with helical tomotherapy
  (hT) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS).
  Methods: Twenty-eight patients with DCIS underwent postoperative hT between 2011
  and 2020. hT was chosen since it provided optimal target coverage and tolerable
  organ-at-risk doses to the lungs and heart when tangential 3-dimensional conformal
  ...'
disable_comments: true
---
Background: This retrospective study aimed to investigate the outcomes and adverse events (AEs) associated with adjuvant radiotherapy with helical tomotherapy (hT) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). Methods: Twenty-eight patients with DCIS underwent postoperative hT between 2011 and 2020. hT was chosen since it provided optimal target coverage and tolerable organ-at-risk doses to the lungs and heart when tangential 3-dimensional conformal ...